Skip to main content
Premium Trial:

Request an Annual Quote

Sorry, We're All Out


The good news for many cancer patients is that modern cancer medications can go a long way toward treating their diseases. The bad news is that sometimes the cancer drugs are nowhere to be found. Drug shortages are affecting an increasing number of cancer patients, who are becoming more and more frustrated. The New York Times' Roni Caryn Rabin spoke to Jenny Morrill, an ovarian cancer patient, who likened the situation to being in the ocean while the person in the lifeboat nearby apologizes for running out of flotation devices. "A lot of things can go wrong when you're in cancer treatment — your white count can go down, you can become too frail to get treatment, the chemo can stop working," Morrill tells Rabin. "One of the things you never consider is that treatment might just not be available."

Morrill isn't alone. In 2011, more than 251 drugs were in short supply, including about 20 chemotherapy drugs, Rabin says. Part of the problem is that recent consolidations and mergers in the pharmaceutical industry have left the burden of manufacturing these drugs on a smaller number of companies, Rabin says. "That means greater repercussions when any single plant experiences production problems, cannot obtain ingredients or fails an inspection, as happened with [Morrill's chemotherapy drug] Doxil," she adds.

Experts say patients should talk to their physicians about the drugs they're taking and whether they're at risk for a shortage or are eligible for substitutions. There may also be a waiting list for drugs, Rabin says. In addition, doctors warn against buying drugs on the internet or from foreign countries as they may not be safe.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.